Increasing Prevalence of Skin Diseases Powering Muscle Relaxant Drug Sales

With the rising incidence of skin diseases, the demand for muscle relaxant drugs is surging sharply across the world. Some of the major factors fueling the incidence of these diseases are the increasing pollution levels, the excessive exposure to ultraviolet (UV) radiation, and increasing tobacco and alcohol consumption. Moreover, exposure to UV rays causes reduction in skin elasticity and also makes the skin highly vulnerable to sunburns, thereby pushing up the requirement for muscle relaxant drugs.

Apart from the aforementioned factor, the rising prevalence of acne is also powering the sales of muscle relaxant drugs around the world. This is because botulinum toxin-based muscle relaxant procedures are required for treating this disease. The surging spending on various facial aesthetic treatment procedures, on account of the growing disposable income of people, and the soaring usage of neuromuscular blocking agents in surgeries are also powering the sales of these drugs.

Geographically, the demand for muscle relaxant drugs was observed to be the highest in North America in the years gone by. This was because of the large-scale usage of facial muscle relaxants and the existence of a large geriatric population in the region. On the other hand, in the forthcoming years, the sales of these drugs will shoot up in Asia, primarily due to the rapidly improving healthcare infrastructure and the increasing volume of surgeries being performed in the region.

Hence, it can be said without any hesitation that the demand for muscle relaxant drugs will rise enormously in the years to come, primarily because of the growing incidence of skin diseases and the ballooning population of ageing people all over the world.